University of Michigan/Kellogg Eye Center

Ann Arbor, Michigan 48105

11 studies enrolling now · 51 studies all time

What they study most

AMD, Age - Related Macular Degeneration (AMD), Age-Related Macular Degeneration, Age-related Macular Degeneration, Atopic Keratoconjunctivitis, Brimonidine Tartrate, Cone Rod Dystrophy, Cornea Preservation Time, Corneal Endothelial Decompensation, Corneal Transplant Failure, Deaf Blind, Diabetic Retinopathy

Studies at this site

• Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD — Recruiting now
• Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants — Recruiting now
• ExCrossV Multi Site Trial for Vascularized High Risk Keratoplasty — Recruiting now
• Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH) — Recruiting now
• Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium — Recruiting now
• Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) — Recruiting now
• Safety and Tolerability of RPE Stem Cell-derived RPE(RPESC-RPE) Transplantation in Patients With Dry Age-related Macular Degeneration (AMD) — Recruiting now
• Clarifying the Optimal Application of SLT Therapy Trial — Recruiting now
• Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Thyroid Eye Disease — Completed
• Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene — Running, not enrolling
• A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP) — Running, not enrolling
• Oral N-acetylcysteine for Retinitis Pigmentosa — Running, not enrolling
• MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) — Completed
• SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects — Completed
• Vamikibart in Participants With Uveitic Macular Edema — Completed
• Zimura Compared to Sham in Patients With Autosomal Recessive Stargardt Disease (STGD1) — Completed
• Natural History of PRPF31 Mutation-Associated Retinal Dystrophy — Running, not enrolling
• Effect of Donor Diabetes and Other Factors on Corneal Transplant Endothelial Cell Loss and Success at 5 Years — Enrolling by invitation
• Study of Serine Supplementation to Protect Vision in MacTel — Starting soon
• REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients — Completed
• Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (MacTel) — Completed
• Automated Quantitative Ulcer Analysis Study — Completed
• Safety Study to Evaluate Bilateral CNTF Implants in Subjects With MacTel Type 2 — Completed
• 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) — Running, not enrolling
• A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy — Completed
• A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B — Completed
• An Open-Label Extension Study to Evaluate Safety & Tolerability of QR-421a in Subjects With Retinitis Pigmentosa — Stopped early
• Study to Evaluate the Efficacy Safety and Tolerability of Ultevursen in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene (Sirius) — Stopped early
• Safety and Efficacy of Emixustat in Stargardt Disease — Completed
• A Phase 2 Study to Assess the Safety and Efficacy of Intravitreal ONL1204 Ophthalmic Solution in Subjects With Mac-off Retinal Detachment — Completed
• Evaluation of Dupilumab in Patients With Atopic Keratoconjunctivitis (AKC) — Status unconfirmed
• Device for Age-related Macular Degeneration (AMD) — Completed
• Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma — Completed
• Safety and Efficacy of rAAV-hRS1 in Patients With X-linked Retinoschisis (XLRS) — Completed
• ASCEND GO-2: Study of RVT-1401 for the Treatment of Participants With Active, Moderate to Severe Graves' Ophthalmopathy ( GO ) — Stopped early
• Dry Eye Assessment and Management Study — Completed
• Study of the Intravitreal Implantation of NT-503-3 Encapsulated Cell Technology (ECT) for the Treatment of Recurrent Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD) — Stopped early
• Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host Disease — Stopped early
• Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene — Completed
• New Enrollment Post-Approval Study of the Argus® II Retinal Prosthesis System — Stopped early
• A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration — Stopped early
• Intense Pulsed Light Study for Dry Eye Disease — Completed
• eSight Eyewear Quality of Life and Efficacy Study — Completed
• Long-Term Safety of Lampalizumab Intravitreal (ITV) Injections in Participants With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (OMASPECT) — Stopped early
• Post-Approval Study of the Implantable Miniature Telescope — Enrolling by invitation
• A Phase 2 Multicenter Randomized Clinical Trial of CNTF for MacTel — Completed
• Telescope Exchange Study — Status unconfirmed
• Cornea Preservation Time Study — Completed
• Clinical Evaluation of Patients With X-linked Retinoschisis — Completed
• The Pathogenesis of Idiopathic Dry Eyes — Completed